Nakagawa, T.; Oda, G.; Kawachi, H.; Ishikawa, T.; Okamoto, K.; Uetake, H.
Nuclear Expression of p-STAT3 Is Associated with Poor Prognosis in ER(−) Breast Cancer. Clin. Pract. 2022, 12, 157-167.
https://doi.org/10.3390/clinpract12020020
AMA Style
Nakagawa T, Oda G, Kawachi H, Ishikawa T, Okamoto K, Uetake H.
Nuclear Expression of p-STAT3 Is Associated with Poor Prognosis in ER(−) Breast Cancer. Clinics and Practice. 2022; 12(2):157-167.
https://doi.org/10.3390/clinpract12020020
Chicago/Turabian Style
Nakagawa, Tsuyoshi, Goshi Oda, Hiroshi Kawachi, Toshiaki Ishikawa, Kentaro Okamoto, and Hiroyuki Uetake.
2022. "Nuclear Expression of p-STAT3 Is Associated with Poor Prognosis in ER(−) Breast Cancer" Clinics and Practice 12, no. 2: 157-167.
https://doi.org/10.3390/clinpract12020020
APA Style
Nakagawa, T., Oda, G., Kawachi, H., Ishikawa, T., Okamoto, K., & Uetake, H.
(2022). Nuclear Expression of p-STAT3 Is Associated with Poor Prognosis in ER(−) Breast Cancer. Clinics and Practice, 12(2), 157-167.
https://doi.org/10.3390/clinpract12020020